Agilent Technologies, Inc. (NYSE:A) Shares Acquired by Advisors Asset Management Inc.

Advisors Asset Management Inc. lifted its position in shares of Agilent Technologies, Inc. (NYSE:AGet Rating) by 26.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,965 shares of the medical research company’s stock after purchasing an additional 1,248 shares during the period. Advisors Asset Management Inc.’s holdings in Agilent Technologies were worth $708,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in A. Walleye Capital LLC acquired a new stake in Agilent Technologies in the second quarter valued at $472,000. Machina Capital S.A.S. raised its holdings in Agilent Technologies by 56.3% in the second quarter. Machina Capital S.A.S. now owns 2,501 shares of the medical research company’s stock valued at $297,000 after acquiring an additional 901 shares in the last quarter. Lmcg Investments LLC raised its holdings in Agilent Technologies by 4.2% in the second quarter. Lmcg Investments LLC now owns 67,674 shares of the medical research company’s stock valued at $8,038,000 after acquiring an additional 2,746 shares in the last quarter. Baird Financial Group Inc. raised its holdings in Agilent Technologies by 3.8% in the second quarter. Baird Financial Group Inc. now owns 23,991 shares of the medical research company’s stock valued at $2,849,000 after acquiring an additional 886 shares in the last quarter. Finally, Kentucky Retirement Systems Insurance Trust Fund raised its holdings in Agilent Technologies by 15.6% in the second quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 10,253 shares of the medical research company’s stock valued at $1,218,000 after acquiring an additional 1,387 shares in the last quarter.

Insider Transactions at Agilent Technologies

In other news, VP Padraig Mcdonnell sold 2,103 shares of the stock in a transaction that occurred on Wednesday, September 28th. The shares were sold at an average price of $122.89, for a total value of $258,437.67. Following the completion of the sale, the vice president now directly owns 13,217 shares of the company’s stock, valued at $1,624,237.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, VP Padraig Mcdonnell sold 2,103 shares of the stock in a transaction that occurred on Wednesday, September 28th. The stock was sold at an average price of $122.89, for a total value of $258,437.67. Following the transaction, the vice president now owns 13,217 shares in the company, valued at $1,624,237.13. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Michael Tang sold 3,600 shares of the stock in a transaction that occurred on Tuesday, November 1st. The shares were sold at an average price of $139.50, for a total value of $502,200.00. Following the transaction, the senior vice president now owns 43,280 shares in the company, valued at approximately $6,037,560. The disclosure for this sale can be found here. Insiders sold 28,534 shares of company stock valued at $3,842,160 over the last three months.

Agilent Technologies Price Performance

A stock opened at $144.44 on Friday. The company has a current ratio of 1.94, a quick ratio of 1.41 and a debt-to-equity ratio of 0.54. Agilent Technologies, Inc. has a one year low of $112.52 and a one year high of $165.68. The firm has a market capitalization of $42.76 billion, a PE ratio of 32.90, a P/E/G ratio of 2.70 and a beta of 1.06. The firm has a 50-day moving average of $132.80 and a two-hundred day moving average of $127.64.

Agilent Technologies (NYSE:AGet Rating) last posted its quarterly earnings data on Tuesday, August 16th. The medical research company reported $1.34 EPS for the quarter, beating analysts’ consensus estimates of $1.20 by $0.14. Agilent Technologies had a net margin of 19.94% and a return on equity of 28.46%. The company had revenue of $1.72 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same period in the prior year, the firm earned $1.10 earnings per share. The business’s quarterly revenue was up 8.3% on a year-over-year basis. On average, analysts forecast that Agilent Technologies, Inc. will post 5.07 earnings per share for the current year.

Agilent Technologies Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 25th. Stockholders of record on Tuesday, January 3rd will be given a $0.225 dividend. This represents a $0.90 dividend on an annualized basis and a dividend yield of 0.62%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.21. The ex-dividend date is Friday, December 30th. Agilent Technologies’s dividend payout ratio is 19.13%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on A. Robert W. Baird boosted their target price on shares of Agilent Technologies from $155.00 to $160.00 and gave the company an “outperform” rating in a research note on Wednesday, August 17th. StockNews.com assumed coverage on shares of Agilent Technologies in a research report on Wednesday, October 12th. They set a “strong-buy” rating for the company. Cowen upped their price target on shares of Agilent Technologies to $160.00 in a research report on Monday, August 22nd. Credit Suisse Group assumed coverage on shares of Agilent Technologies in a research report on Wednesday, August 24th. They set an “outperform” rating and a $165.00 price target for the company. Finally, Bank of America upped their price target on shares of Agilent Technologies from $148.00 to $155.00 and gave the stock a “buy” rating in a research report on Wednesday, August 17th. Four equities research analysts have rated the stock with a hold rating, nine have issued a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, Agilent Technologies currently has a consensus rating of “Moderate Buy” and a consensus target price of $151.31.

About Agilent Technologies

(Get Rating)

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.

Read More

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.